ANDA 63147, held by Hanford Gc. Ampicillin Sodium.
As of Nov 16, 2026, ANDA 63147 (Ampicillin Sodium), held by Hanford Gc, was first approved by FDA on Apr 15, 1993, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 15, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ampicillin SodiumEQ 500MG BASE/VIAL · injectable;injection | Ampicillin Sodium | Discontinued |
| May 31, 2013 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jul 23, 2007 | Supplement 6Labeling | Approved | None posted |
| Feb 28, 2007 | Supplement 4Labeling | Approved | None posted |
| Feb 14, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Nov 5, 1993 | Supplement 2Manufacturing | Approved | None posted |
| Apr 15, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters